- Home
- CSCI vs DPRO Comparison
CSCI vs DPRO Comparison
Compare CSCI & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSCI
- DPRO
- Stock Information
- Founded
- CSCI 1990
- DPRO 1998
- Country
- CSCI Canada
- DPRO Canada
- Employees
- CSCI N/A
- DPRO N/A
- Industry
- CSCI
- DPRO Aerospace
- Sector
- CSCI
- DPRO Industrials
- Exchange
- CSCI NYSE
- DPRO Nasdaq
- Market Cap
- CSCI 11.1M
- DPRO 9.3M
- IPO Year
- CSCI 1996
- DPRO N/A
- Fundamental
- Price
- CSCI $3.14
- DPRO $2.76
- Analyst Decision
- CSCI
- DPRO Strong Buy
- Analyst Count
- CSCI 0
- DPRO 2
- Target Price
- CSCI N/A
- DPRO $7.00
- AVG Volume (30 Days)
- CSCI 5.3K
- DPRO 58.9K
- Earning Date
- CSCI 11-12-2024
- DPRO 11-14-2024
- Dividend Yield
- CSCI N/A
- DPRO N/A
- EPS Growth
- CSCI N/A
- DPRO N/A
- EPS
- CSCI N/A
- DPRO N/A
- Revenue
- CSCI $4,834,000.00
- DPRO $4,469,286.00
- Revenue This Year
- CSCI N/A
- DPRO $30.90
- Revenue Next Year
- CSCI N/A
- DPRO $112.38
- P/E Ratio
- CSCI N/A
- DPRO N/A
- Revenue Growth
- CSCI N/A
- DPRO N/A
- 52 Week Low
- CSCI $2.81
- DPRO $1.55
- 52 Week High
- CSCI $11.10
- DPRO $15.00
- Technical
- Relative Strength Index (RSI)
- CSCI N/A
- DPRO 49.69
- Support Level
- CSCI N/A
- DPRO $2.25
- Resistance Level
- CSCI N/A
- DPRO $2.60
- Average True Range (ATR)
- CSCI 0.00
- DPRO 0.25
- MACD
- CSCI 0.00
- DPRO -0.00
- Stochastic Oscillator
- CSCI 0.00
- DPRO 64.10
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.